Fidelity Investments’s Dimension Therapeutics, Inc DMTX Stock Holding History

Fidelity Investments’s Portfolio DMTX Stock Details DMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-4,893,322	Closed	-$29.4M	–	2781
2017 Q3	$29.4M	Hold	4,893,322	–	–	﹤0.01%	1553
2017 Q2	$7.09M	Hold	4,893,322	–	–	﹤0.01%	2064
2017 Q1	$8.56M	Hold	4,893,322	–	–	﹤0.01%	2027
2016 Q4	$21.3M	Hold	4,893,322	–	–	﹤0.01%	1652
2016 Q3	$39.1M	Hold	4,893,322	–	–	0.01%	1404
2016 Q2	$29.4M	Sell	4,893,322 -2,106,784	-30%	-$16M	﹤0.01%	1503
2016 Q1	$54.8M	Hold	7,000,106	–	–	0.01%	1212
2015 Q4	$79M	Buy	+7,000,106	New	+$88.6M	0.01%	1062

Fidelity Investments's DMTX Position: Q4 2017 in Review

Fidelity Investments sold out of Dimension Therapeutics, Inc (DMTX) in Q4 2017, closing a stake of 4,893,322 shares — an estimated $29.4M sold.

Fidelity Investments first reported a position in DMTX in Q4 2015 and held it in 8 quarters. The position peaked at $79M in Q4 2015. 0 funds tracked by Wall St. Rank hold DMTX as of Q4 2017.

Fidelity Investments reported no remaining Dimension Therapeutics, Inc position as of Q4 2017 after selling out during the quarter.
Fidelity Investments sold 4,893,322 Dimension Therapeutics, Inc shares in Q4 2017, an estimated $29.4M.
Fidelity Investments first reported a position in Dimension Therapeutics, Inc in Q4 2015 and held it in 8 quarters.
Fidelity Investments's Dimension Therapeutics, Inc position peaked at $79M in Q4 2015.
0 funds tracked by Wall St. Rank held Dimension Therapeutics, Inc as of Q4 2017.

Based on Fidelity Investments's 13F filing for Q4 2017, filed 12 Feb 2018.